Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Geriatric Oncology SuPportive Clinic for ELderly
Authors not listed
Goh Wen Yang · 2020
Abstract
This is a randomized controlled trial comparing the impact of Geriatric-Oncology-Supportive Clinic (GOSC) on quality of life in older adult with newly diagnosed cancer undergoing cancer related treatment.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-11 MST
Cite this
APA
Anonymous. (2020). Geriatric Oncology SuPportive Clinic for ELderly. <em>Goh Wen Yang</em>. https://clinicaltrials.gov/study/NCT04513977
Vancouver
Anonymous. Geriatric Oncology SuPportive Clinic for ELderly. Goh Wen Yang. 2020.
BibTeX
@misc{anon2020Geriat,
title = {Geriatric Oncology SuPportive Clinic for ELderly},
author = {Anonymous},
journal = {Goh Wen Yang},
year = {2020},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Royal Marsden NHS Foundation Trust 2020
Open access · US-GOV
Feasibility of Frailty Assessment and Implementation of Protocol-led Geriatric Interventions in Women Over the Age of 70 With Epithelial Ovarian Cancer in the Oncology Clinic (FAIR-O)
Parc de Salut Mar 2019
Open access · US-GOV
The Impact of Frailty on the Postoperative Outcomes of Gastric Cancer Surgery
Spanish Lung Cancer Group 2017
Open access · US-GOV
Survival, Quality of Life and Self-reported Outcomes of Elderly Patients With Advanced Non-small Cell Lung Cancer Treated With Pembrolizumab (MK-3475) in the First Line Setting
SCRI Development Innovations, LLC 2007
Open access · US-GOV
A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients With Advanced Non-Small Cell Lung Cancer
Kosin University Gospel Hospital 2017
Open access · US-GOV
A Phase 2 Trial of Pre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCL
Nature Cell Biology 2018
Citation only